VivoSim Labs, Inc. Operating Expenses
VivoSim Labs, Inc. (VIVS) reported Operating Expenses of $3.49 million for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-02-09
- VivoSim Labs, Inc. operating expenses for the quarter ending 2022-12-31 was $3.49M, a 0.29% decline year-over-year.
- VivoSim Labs, Inc. operating expenses for the quarter ending 2022-09-30 was $3.43M, a 2.17% decline year-over-year.
- VivoSim Labs, Inc. operating expenses for the quarter ending 2022-06-30 was $3.24M, a 26.57% increase year-over-year.
- VivoSim Labs, Inc. operating expenses for the quarter ending 2021-12-31 was $3.50M, a 40.45% increase year-over-year.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 21 month | Operating Expenses 24 month |
|---|---|---|---|---|---|
| 2022-12-31 | $3.49M 10-Q · filed 2023-02-09 | $6.92M derived: sum of 2 quarters · filed 2023-02-09 | $10.16M 10-Q · filed 2023-02-09 | ||
| 2022-09-30 | $3.43M 10-Q · filed 2022-11-10 | $6.67M 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $3.24M 10-Q · filed 2022-08-11 | ||||
| 2021-12-31 | $3.50M 10-Q · filed 2023-02-09 | $7.01M derived: sum of 2 quarters · filed 2023-02-09 | $9.57M 10-Q · filed 2023-02-09 | ||
| 2021-09-30 | $3.51M 10-Q · filed 2022-11-10 | $6.07M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $2.56M 10-Q · filed 2022-08-11 | ||||
| 2020-12-31 | $2.49M 10-Q · filed 2022-02-14 | $11.44M derived: sum of 2 quarters · filed 2022-02-14 | $14.23M 10-Q · filed 2022-02-14 | ||
| 2020-09-30 | $8.95M 10-Q · filed 2021-11-08 | $11.74M 10-Q · filed 2021-11-08 | |||
| 2011-12-31 | $43.51K 10-Q · filed 2012-01-17 | $68.63K 10-Q · filed 2012-01-17 | $254.37K 10-Q · filed 2012-01-17 | ||
| 2011-09-30 | $25.12K 10-Q · filed 2011-10-31 | $210.86K 10-Q · filed 2011-10-31 | |||
| 2010-12-31 | $29.83K 10-Q · filed 2012-01-17 | $55.55K 10-Q · filed 2012-01-17 | |||
| 2010-09-30 | $25.72K 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |